cloudfront

Report Detail

Pharma & Healthcare Global Dermatophytosis Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • RnM2541468
  • |
  • 06 November, 2018
  • |
  • Global
  • |
  • 121 pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Global Dermatophytosis Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

    1 Market Overview

    • 1.1 Dermatophytosis Drugs Introduction
    • 1.2 Market Analysis by Type
    • 1.2.1 Rx
  • 1.2.2 OTC
  • 1.3 Market Analysis by Applications
  • 1.3.1 Hospital
  • 1.3.2 Clinic
  • 1.3.3 Other
  • 1.4 Market Analysis by Regions
  • 1.4.1 North America (United States, Canada and Mexico)
  • 1.4.1.1 United States Market States and Outlook (2013-2023)
  • 1.4.1.2 Canada Market States and Outlook (2013-2023)
  • 1.4.1.3 Mexico Market States and Outlook (2013-2023)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
  • 1.4.2.1 Germany Market States and Outlook (2013-2023)
  • 1.4.2.2 France Market States and Outlook (2013-2023)
  • 1.4.2.3 UK Market States and Outlook (2013-2023)
  • 1.4.2.4 Russia Market States and Outlook (2013-2023)
  • 1.4.2.5 Italy Market States and Outlook (2013-2023)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • 1.4.3.1 China Market States and Outlook (2013-2023)
  • 1.4.3.2 Japan Market States and Outlook (2013-2023)
  • 1.4.3.3 Korea Market States and Outlook (2013-2023)
  • 1.4.3.4 India Market States and Outlook (2013-2023)
  • 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  • 1.4.4 South America, Middle East and Africa
  • 1.4.4.1 Brazil Market States and Outlook (2013-2023)
  • 1.4.4.2 Egypt Market States and Outlook (2013-2023)
  • 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
  • 1.4.4.4 South Africa Market States and Outlook (2013-2023)
  • 1.4.4.5 Nigeria Market States and Outlook (2013-2023)
  • 1.5 Market Dynamics
  • 1.5.1 Market Opportunities
  • 1.5.2 Market Risk
  • 1.5.3 Market Driving Force
  • 2 Manufacturers Profiles

    • 2.1 Novartis
    • 2.1.1 Business Overview
  • 2.1.2 Dermatophytosis Drugs Type and Applications
  • 2.1.2.1 Product A
  • 2.1.2.2 Product B
  • 2.1.3 Novartis Dermatophytosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.2 Pfizer
  • 2.2.1 Business Overview
  • 2.2.2 Dermatophytosis Drugs Type and Applications
  • 2.2.2.1 Product A
  • 2.2.2.2 Product B
  • 2.2.3 Pfizer Dermatophytosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.3 Sanofi-Aventis
  • 2.3.1 Business Overview
  • 2.3.2 Dermatophytosis Drugs Type and Applications
  • 2.3.2.1 Product A
  • 2.3.2.2 Product B
  • 2.3.3 Sanofi-Aventis Dermatophytosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.4 Merck
  • 2.4.1 Business Overview
  • 2.4.2 Dermatophytosis Drugs Type and Applications
  • 2.4.2.1 Product A
  • 2.4.2.2 Product B
  • 2.4.3 Merck Dermatophytosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.5 Enzon Pharmaceuticals
  • 2.5.1 Business Overview
  • 2.5.2 Dermatophytosis Drugs Type and Applications
  • 2.5.2.1 Product A
  • 2.5.2.2 Product B
  • 2.5.3 Enzon Pharmaceuticals Dermatophytosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.6 Bayer
  • 2.6.1 Business Overview
  • 2.6.2 Dermatophytosis Drugs Type and Applications
  • 2.6.2.1 Product A
  • 2.6.2.2 Product B
  • 2.6.3 Bayer Dermatophytosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.7 Astellas Pharma
  • 2.7.1 Business Overview
  • 2.7.2 Dermatophytosis Drugs Type and Applications
  • 2.7.2.1 Product A
  • 2.7.2.2 Product B
  • 2.7.3 Astellas Pharma Dermatophytosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.8 GSK
  • 2.8.1 Business Overview
  • 2.8.2 Dermatophytosis Drugs Type and Applications
  • 2.8.2.1 Product A
  • 2.8.2.2 Product B
  • 2.8.3 GSK Dermatophytosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.9 Abbott
  • 2.9.1 Business Overview
  • 2.9.2 Dermatophytosis Drugs Type and Applications
  • 2.9.2.1 Product A
  • 2.9.2.2 Product B
  • 2.9.3 Abbott Dermatophytosis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 3 Global Dermatophytosis Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

    • 3.1 Global Dermatophytosis Drugs Sales and Market Share by Manufacturer (2016-2017)
    • 3.2 Global Dermatophytosis Drugs Revenue and Market Share by Manufacturer (2016-2017)
    • 3.3 Market Concentration Rate
    • 3.3.1 Top 3 Dermatophytosis Drugs Manufacturer Market Share in 2017
  • 3.3.2 Top 6 Dermatophytosis Drugs Manufacturer Market Share in 2017
  • 3.4 Market Competition Trend
  • 4 Global Dermatophytosis Drugs Market Analysis by Regions

    • 4.1 Global Dermatophytosis Drugs Sales, Revenue and Market Share by Regions
    • 4.1.1 Global Dermatophytosis Drugs Sales and Market Share by Regions (2013-2018)
  • 4.1.2 Global Dermatophytosis Drugs Revenue and Market Share by Regions (2013-2018)
  • 4.2 North America Dermatophytosis Drugs Sales and Growth Rate (2013-2018)
  • 4.3 Europe Dermatophytosis Drugs Sales and Growth Rate (2013-2018)
  • 4.4 Asia-Pacific Dermatophytosis Drugs Sales and Growth Rate (2013-2018)
  • 4.5 South America Dermatophytosis Drugs Sales and Growth Rate (2013-2018)
  • 4.6 Middle East and Africa Dermatophytosis Drugs Sales and Growth Rate (2013-2018)
  • 5 North America Dermatophytosis Drugs by Countries

    • 5.1 North America Dermatophytosis Drugs Sales, Revenue and Market Share by Countries
    • 5.1.1 North America Dermatophytosis Drugs Sales and Market Share by Countries (2013-2018)
  • 5.1.2 North America Dermatophytosis Drugs Revenue and Market Share by Countries (2013-2018)
  • 5.2 United States Dermatophytosis Drugs Sales and Growth Rate (2013-2018)
  • 5.3 Canada Dermatophytosis Drugs Sales and Growth Rate (2013-2018)
  • 5.4 Mexico Dermatophytosis Drugs Sales and Growth Rate (2013-2018)
  • 6 Europe Dermatophytosis Drugs by Countries

    • 6.1 Europe Dermatophytosis Drugs Sales, Revenue and Market Share by Countries
    • 6.1.1 Europe Dermatophytosis Drugs Sales and Market Share by Countries (2013-2018)
  • 6.1.2 Europe Dermatophytosis Drugs Revenue and Market Share by Countries (2013-2018)
  • 6.2 Germany Dermatophytosis Drugs Sales and Growth Rate (2013-2018)
  • 6.3 UK Dermatophytosis Drugs Sales and Growth Rate (2013-2018)
  • 6.4 France Dermatophytosis Drugs Sales and Growth Rate (2013-2018)
  • 6.5 Russia Dermatophytosis Drugs Sales and Growth Rate (2013-2018)
  • 6.6 Italy Dermatophytosis Drugs Sales and Growth Rate (2013-2018)
  • 7 Asia-Pacific Dermatophytosis Drugs by Countries

    • 7.1 Asia-Pacific Dermatophytosis Drugs Sales, Revenue and Market Share by Countries
    • 7.1.1 Asia-Pacific Dermatophytosis Drugs Sales and Market Share by Countries (2013-2018)
  • 7.1.2 Asia-Pacific Dermatophytosis Drugs Revenue and Market Share by Countries (2013-2018)
  • 7.2 China Dermatophytosis Drugs Sales and Growth Rate (2013-2018)
  • 7.3 Japan Dermatophytosis Drugs Sales and Growth Rate (2013-2018)
  • 7.4 Korea Dermatophytosis Drugs Sales and Growth Rate (2013-2018)
  • 7.5 India Dermatophytosis Drugs Sales and Growth Rate (2013-2018)
  • 7.6 Southeast Asia Dermatophytosis Drugs Sales and Growth Rate (2013-2018)
  • 8 South America Dermatophytosis Drugs by Countries

    • 8.1 South America Dermatophytosis Drugs Sales, Revenue and Market Share by Countries
    • 8.1.1 South America Dermatophytosis Drugs Sales and Market Share by Countries (2013-2018)
  • 8.1.2 South America Dermatophytosis Drugs Revenue and Market Share by Countries (2013-2018)
  • 8.2 Brazil Dermatophytosis Drugs Sales and Growth Rate (2013-2018)
  • 8.3 Argentina Dermatophytosis Drugs Sales and Growth Rate (2013-2018)
  • 8.4 Colombia Dermatophytosis Drugs Sales and Growth Rate (2013-2018)
  • 9 Middle East and Africa Dermatophytosis Drugs by Countries

    • 9.1 Middle East and Africa Dermatophytosis Drugs Sales, Revenue and Market Share by Countries
    • 9.1.1 Middle East and Africa Dermatophytosis Drugs Sales and Market Share by Countries (2013-2018)
  • 9.1.2 Middle East and Africa Dermatophytosis Drugs Revenue and Market Share by Countries (2013-2018)
  • 9.2 Saudi Arabia Dermatophytosis Drugs Sales and Growth Rate (2013-2018)
  • 9.3 UAE Dermatophytosis Drugs Sales and Growth Rate (2013-2018)
  • 9.4 Egypt Dermatophytosis Drugs Sales and Growth Rate (2013-2018)
  • 9.5 Nigeria Dermatophytosis Drugs Sales and Growth Rate (2013-2018)
  • 9.6 South Africa Dermatophytosis Drugs Sales and Growth Rate (2013-2018)
  • 10 Global Dermatophytosis Drugs Market Segment by Type

    • 10.1 Global Dermatophytosis Drugs Sales, Revenue and Market Share by Type (2013-2018)
    • 10.1.1 Global Dermatophytosis Drugs Sales and Market Share by Type (2013-2018)
  • 10.1.2 Global Dermatophytosis Drugs Revenue and Market Share by Type (2013-2018)
  • 10.2 Rx Sales Growth and Price
  • 10.2.1 Global Rx Sales Growth (2013-2018)
  • 10.2.2 Global Rx Price (2013-2018)
  • 10.3 OTC Sales Growth and Price
  • 10.3.1 Global OTC Sales Growth (2013-2018)
  • 10.3.2 Global OTC Price (2013-2018)
  • 11 Global Dermatophytosis Drugs Market Segment by Application

    • 11.1 Global Dermatophytosis Drugs Sales Market Share by Application (2013-2018)
    • 11.2 Hospital Sales Growth (2013-2018)
    • 11.3 Clinic Sales Growth (2013-2018)
    • 11.4 Other Sales Growth (2013-2018)

    12 Dermatophytosis Drugs Market Forecast (2018-2023)

    • 12.1 Global Dermatophytosis Drugs Sales, Revenue and Growth Rate (2018-2023)
    • 12.2 Dermatophytosis Drugs Market Forecast by Regions (2018-2023)
    • 12.2.1 North America Dermatophytosis Drugs Market Forecast (2018-2023)
  • 12.2.2 Europe Dermatophytosis Drugs Market Forecast (2018-2023)
  • 12.2.3 Asia-Pacific Dermatophytosis Drugs Market Forecast (2018-2023)
  • 12.2.4 South America Dermatophytosis Drugs Market Forecast (2018-2023)
  • 12.2.5 Middle East and Africa Dermatophytosis Drugs Market Forecast (2018-2023)
  • 12.3 Dermatophytosis Drugs Market Forecast by Type (2018-2023)
  • 12.3.1 Global Dermatophytosis Drugs Sales Forecast by Type (2018-2023)
  • 12.3.2 Global Dermatophytosis Drugs Market Share Forecast by Type (2018-2023)
  • 12.4 Dermatophytosis Drugs Market Forecast by Application (2018-2023)
  • 12.4.1 Global Dermatophytosis Drugs Sales Forecast by Application (2018-2023)
  • 12.4.2 Global Dermatophytosis Drugs Market Share Forecast by Application (2018-2023)
  • 13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
    • 13.1.1 Direct Marketing
  • 13.1.2 Indirect Marketing
  • 13.1.3 Marketing Channel Future Trend
  • 13.2 Distributors, Traders and Dealers
  • 14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Ringworm on the skin like athlete's foot (tinea pedis) and jock itch (tinea cruris) can usually be treated with non-prescription antifungal creams, lotions, or powders applied to the skin for 2 to 4 weeks.

      Scope of the Report:

      The worldwide market for Dermatophytosis Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

      This report focuses on the Dermatophytosis Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Market Segment by Manufacturers, this report covers

      Novartis

      Pfizer

      Sanofi-Aventis

      Merck

      Enzon Pharmaceuticals

      Bayer

      Astellas Pharma

      GSK

      Abbott

      Market Segment by Regions, regional analysis covers

      North America (United States, Canada and Mexico)

      Europe (Germany, France, UK, Russia and Italy)

      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

      South America (Brazil, Argentina, Colombia etc.)

      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers

      Rx

      OTC

      Market Segment by Applications, can be divided into

      Hospital

      Clinic

      Other

      There are 15 Chapters to deeply display the global Dermatophytosis Drugs market.

      Chapter 1, to describe Dermatophytosis Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

      Chapter 2, to analyze the top manufacturers of Dermatophytosis Drugs, with sales, revenue, and price of Dermatophytosis Drugs, in 2016 and 2017;

      Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

      Chapter 4, to show the global market by regions, with sales, revenue and market share of Dermatophytosis Drugs, for each region, from 2013 to 2018;

      Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

      Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

      Chapter 12, Dermatophytosis Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

      Chapter 13, 14 and 15, to describe Dermatophytosis Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source




      Summary:
      Get latest Market Research Reports on Dermatophytosis Drugs . Industry analysis & Market Report on Dermatophytosis Drugs is a syndicated market report, published as Global Dermatophytosis Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023. It is complete Research Study and Industry Analysis of Dermatophytosis Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,336.82
      3,505.23
      4,673.64
      3,202.30
      4,803.44
      6,404.59
      421,567.20
      632,350.80
      843,134.40
      230,770.63
      346,155.95
      461,541.26
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report